A contrast agent (or contrast medium) is a substance used to increase the contrast of structures or fluids within the body in medical imaging.
The global Interventional X-ray Contrast and Imaging Agents market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Interventional X-ray Contrast and Imaging Agents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Interventional X-ray Contrast and Imaging Agents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Interventional X-ray Contrast and Imaging Agents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Interventional X-ray Contrast and Imaging Agents include Bracco, General Electric, Guerbet, Fujifilm Visualsonics, Imax, J.B. Chemicals & Pharmaceuticals, Jodas Expoim, Lantheus Medical Imaging and Nano Therapeutics, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Interventional X-ray Contrast and Imaging Agents, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Interventional X-ray Contrast and Imaging Agents, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Interventional X-ray Contrast and Imaging Agents, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Interventional X-ray Contrast and Imaging Agents sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Interventional X-ray Contrast and Imaging Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Interventional X-ray Contrast and Imaging Agents sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Guerbet
Fujifilm Visualsonics
Imax
J.B. Chemicals & Pharmaceuticals
Jodas Expoim
Lantheus Medical Imaging
Nano Therapeutics
Novalek Pharmaceuticals
Taejoon Pharm
Unijules Life Sciences
Segment by Type
Iodinated Contrast Media
Barium-Based Contrast Media
Microbubble Contrast Media
Other
Segment by Application
Heart Disease
Neurological
Urology
General Surgery
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Interventional X-ray Contrast and Imaging Agents in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Interventional X-ray Contrast and Imaging Agents manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Interventional X-ray Contrast and Imaging Agents sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Interventional X-ray Contrast and Imaging Agents Product Introduction
1.2 Market by Type
1.2.1 Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Iodinated Contrast Media
1.2.3 Barium-Based Contrast Media
1.2.4 Microbubble Contrast Media
1.2.5 Other
1.3 Market by Application
1.3.1 Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Heart Disease
1.3.3 Neurological
1.3.4 Urology
1.3.5 General Surgery
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Interventional X-ray Contrast and Imaging Agents Sales Estimates and Forecasts 2019-2030
2.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Region
2.2.1 Global Interventional X-ray Contrast and Imaging Agents Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Region (2019-2024)
2.2.3 Global Interventional X-ray Contrast and Imaging Agents Revenue by Region (2025-2030)
2.2.4 Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Region (2019-2030)
2.3 Global Interventional X-ray Contrast and Imaging Agents Sales Estimates and Forecasts 2019-2030
2.4 Global Interventional X-ray Contrast and Imaging Agents Sales by Region
2.4.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Interventional X-ray Contrast and Imaging Agents Sales by Region (2019-2024)
2.4.3 Global Interventional X-ray Contrast and Imaging Agents Sales by Region (2025-2030)
2.4.4 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Manufacturers
3.1.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Manufacturers (2019-2024)
3.1.2 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Interventional X-ray Contrast and Imaging Agents in 2023
3.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Manufacturers
3.2.1 Global Interventional X-ray Contrast and Imaging Agents Revenue by Manufacturers (2019-2024)
3.2.2 Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Interventional X-ray Contrast and Imaging Agents Revenue in 2023
3.3 Global Key Players of Interventional X-ray Contrast and Imaging Agents, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Interventional X-ray Contrast and Imaging Agents Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Interventional X-ray Contrast and Imaging Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Interventional X-ray Contrast and Imaging Agents, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Interventional X-ray Contrast and Imaging Agents, Product Offered and Application
3.8 Global Key Manufacturers of Interventional X-ray Contrast and Imaging Agents, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Type
4.1.1 Global Interventional X-ray Contrast and Imaging Agents Historical Sales by Type (2019-2024)
4.1.2 Global Interventional X-ray Contrast and Imaging Agents Forecasted Sales by Type (2025-2030)
4.1.3 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2019-2030)
4.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Type
4.2.1 Global Interventional X-ray Contrast and Imaging Agents Historical Revenue by Type (2019-2024)
4.2.2 Global Interventional X-ray Contrast and Imaging Agents Forecasted Revenue by Type (2025-2030)
4.2.3 Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Type (2019-2030)
4.3 Global Interventional X-ray Contrast and Imaging Agents Price by Type
4.3.1 Global Interventional X-ray Contrast and Imaging Agents Price by Type (2019-2024)
4.3.2 Global Interventional X-ray Contrast and Imaging Agents Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Application
5.1.1 Global Interventional X-ray Contrast and Imaging Agents Historical Sales by Application (2019-2024)
5.1.2 Global Interventional X-ray Contrast and Imaging Agents Forecasted Sales by Application (2025-2030)
5.1.3 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2019-2030)
5.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Application
5.2.1 Global Interventional X-ray Contrast and Imaging Agents Historical Revenue by Application (2019-2024)
5.2.2 Global Interventional X-ray Contrast and Imaging Agents Forecasted Revenue by Application (2025-2030)
5.2.3 Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Application (2019-2030)
5.3 Global Interventional X-ray Contrast and Imaging Agents Price by Application
5.3.1 Global Interventional X-ray Contrast and Imaging Agents Price by Application (2019-2024)
5.3.2 Global Interventional X-ray Contrast and Imaging Agents Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Interventional X-ray Contrast and Imaging Agents Market Size by Type
6.1.1 US & Canada Interventional X-ray Contrast and Imaging Agents Sales by Type (2019-2030)
6.1.2 US & Canada Interventional X-ray Contrast and Imaging Agents Revenue by Type (2019-2030)
6.2 US & Canada Interventional X-ray Contrast and Imaging Agents Market Size by Application
6.2.1 US & Canada Interventional X-ray Contrast and Imaging Agents Sales by Application (2019-2030)
6.2.2 US & Canada Interventional X-ray Contrast and Imaging Agents Revenue by Application (2019-2030)
6.3 US & Canada Interventional X-ray Contrast and Imaging Agents Market Size by Country
6.3.1 US & Canada Interventional X-ray Contrast and Imaging Agents Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Interventional X-ray Contrast and Imaging Agents Sales by Country (2019-2030)
6.3.3 US & Canada Interventional X-ray Contrast and Imaging Agents Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Interventional X-ray Contrast and Imaging Agents Market Size by Type
7.1.1 Europe Interventional X-ray Contrast and Imaging Agents Sales by Type (2019-2030)
7.1.2 Europe Interventional X-ray Contrast and Imaging Agents Revenue by Type (2019-2030)
7.2 Europe Interventional X-ray Contrast and Imaging Agents Market Size by Application
7.2.1 Europe Interventional X-ray Contrast and Imaging Agents Sales by Application (2019-2030)
7.2.2 Europe Interventional X-ray Contrast and Imaging Agents Revenue by Application (2019-2030)
7.3 Europe Interventional X-ray Contrast and Imaging Agents Market Size by Country
7.3.1 Europe Interventional X-ray Contrast and Imaging Agents Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Interventional X-ray Contrast and Imaging Agents Sales by Country (2019-2030)
7.3.3 Europe Interventional X-ray Contrast and Imaging Agents Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Interventional X-ray Contrast and Imaging Agents Market Size
8.1.1 China Interventional X-ray Contrast and Imaging Agents Sales (2019-2030)
8.1.2 China Interventional X-ray Contrast and Imaging Agents Revenue (2019-2030)
8.2 China Interventional X-ray Contrast and Imaging Agents Market Size by Application
8.2.1 China Interventional X-ray Contrast and Imaging Agents Sales by Application (2019-2030)
8.2.2 China Interventional X-ray Contrast and Imaging Agents Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Interventional X-ray Contrast and Imaging Agents Market Size by Type
9.1.1 Asia Interventional X-ray Contrast and Imaging Agents Sales by Type (2019-2030)
9.1.2 Asia Interventional X-ray Contrast and Imaging Agents Revenue by Type (2019-2030)
9.2 Asia Interventional X-ray Contrast and Imaging Agents Market Size by Application
9.2.1 Asia Interventional X-ray Contrast and Imaging Agents Sales by Application (2019-2030)
9.2.2 Asia Interventional X-ray Contrast and Imaging Agents Revenue by Application (2019-2030)
9.3 Asia Interventional X-ray Contrast and Imaging Agents Sales by Region
9.3.1 Asia Interventional X-ray Contrast and Imaging Agents Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Interventional X-ray Contrast and Imaging Agents Revenue by Region (2019-2030)
9.3.3 Asia Interventional X-ray Contrast and Imaging Agents Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Market Size by Type
10.1.1 Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Market Size by Application
10.2.1 Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Sales by Country
10.3.1 Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bracco
11.1.1 Bracco Company Information
11.1.2 Bracco Overview
11.1.3 Bracco Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Bracco Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bracco Recent Developments
11.2 General Electric
11.2.1 General Electric Company Information
11.2.2 General Electric Overview
11.2.3 General Electric Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 General Electric Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 General Electric Recent Developments
11.3 Guerbet
11.3.1 Guerbet Company Information
11.3.2 Guerbet Overview
11.3.3 Guerbet Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Guerbet Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Guerbet Recent Developments
11.4 Fujifilm Visualsonics
11.4.1 Fujifilm Visualsonics Company Information
11.4.2 Fujifilm Visualsonics Overview
11.4.3 Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Fujifilm Visualsonics Recent Developments
11.5 Imax
11.5.1 Imax Company Information
11.5.2 Imax Overview
11.5.3 Imax Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Imax Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Imax Recent Developments
11.6 J.B. Chemicals & Pharmaceuticals
11.6.1 J.B. Chemicals & Pharmaceuticals Company Information
11.6.2 J.B. Chemicals & Pharmaceuticals Overview
11.6.3 J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 J.B. Chemicals & Pharmaceuticals Recent Developments
11.7 Jodas Expoim
11.7.1 Jodas Expoim Company Information
11.7.2 Jodas Expoim Overview
11.7.3 Jodas Expoim Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Jodas Expoim Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Jodas Expoim Recent Developments
11.8 Lantheus Medical Imaging
11.8.1 Lantheus Medical Imaging Company Information
11.8.2 Lantheus Medical Imaging Overview
11.8.3 Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Lantheus Medical Imaging Recent Developments
11.9 Nano Therapeutics
11.9.1 Nano Therapeutics Company Information
11.9.2 Nano Therapeutics Overview
11.9.3 Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Nano Therapeutics Recent Developments
11.10 Novalek Pharmaceuticals
11.10.1 Novalek Pharmaceuticals Company Information
11.10.2 Novalek Pharmaceuticals Overview
11.10.3 Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novalek Pharmaceuticals Recent Developments
11.11 Taejoon Pharm
11.11.1 Taejoon Pharm Company Information
11.11.2 Taejoon Pharm Overview
11.11.3 Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Taejoon Pharm Recent Developments
11.12 Unijules Life Sciences
11.12.1 Unijules Life Sciences Company Information
11.12.2 Unijules Life Sciences Overview
11.12.3 Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Unijules Life Sciences Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Interventional X-ray Contrast and Imaging Agents Industry Chain Analysis
12.2 Interventional X-ray Contrast and Imaging Agents Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Interventional X-ray Contrast and Imaging Agents Production Mode & Process
12.4 Interventional X-ray Contrast and Imaging Agents Sales and Marketing
12.4.1 Interventional X-ray Contrast and Imaging Agents Sales Channels
12.4.2 Interventional X-ray Contrast and Imaging Agents Distributors
12.5 Interventional X-ray Contrast and Imaging Agents Customers
13 Market Dynamics
13.1 Interventional X-ray Contrast and Imaging Agents Industry Trends
13.2 Interventional X-ray Contrast and Imaging Agents Market Drivers
13.3 Interventional X-ray Contrast and Imaging Agents Market Challenges
13.4 Interventional X-ray Contrast and Imaging Agents Market Restraints
14 Key Findings in The Global Interventional X-ray Contrast and Imaging Agents Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Bracco
General Electric
Guerbet
Fujifilm Visualsonics
Imax
J.B. Chemicals & Pharmaceuticals
Jodas Expoim
Lantheus Medical Imaging
Nano Therapeutics
Novalek Pharmaceuticals
Taejoon Pharm
Unijules Life Sciences
听
听
*If Applicable.
